AD variants or knockdown of PLD3 are associated with dysregulated amyloid precursor protein (APP) processing and a concomitant increase in extracellular Aβ levels whereas PLD3 overexpression decreases levels of both [1, 5, 6]. The gene discussed is APP; the disease is Alzheimer disease.